ESCORTS:NSEEscorts Kubota Limited Analysis
Data as of 2026-05-15 - not real-time
₹3,000.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Escorts Kubota is trading below its short‑ and medium‑term moving averages, and the MACD remains in a bearish configuration, suggesting continued short‑term pressure. However, the RSI is hovering near the oversold region, and volume is on an upward trend, indicating that the downside may be limited and a bounce could be on the horizon.
Fundamentally, the company is delivering strong top‑line growth, expanding margins and a solid cash pile that dwarfs its modest debt load, while the dividend payout is low enough to be comfortably sustainable. Valuation metrics point to a price that is below both industry peers and the discounted cash‑flow estimate, implying a meaningful upside potential for patient investors.
Fundamentally, the company is delivering strong top‑line growth, expanding margins and a solid cash pile that dwarfs its modest debt load, while the dividend payout is low enough to be comfortably sustainable. Valuation metrics point to a price that is below both industry peers and the discounted cash‑flow estimate, implying a meaningful upside potential for patient investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price is below key moving averages indicating short‑term weakness
- RSI near oversold suggests limited downside risk
- strong cash position and low debt provide a safety cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- revenue growth and expanding margins support earnings acceleration
- DCF valuation shows clear upside relative to current price
- low beta and a sustainable dividend enhance risk‑adjusted returns
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- robust earnings outlook with improving forward PE
- valuation remains attractive compared with industry averages
- stable dividend policy and strong balance sheet underpin long‑term resilience
Key Metrics & Analysis
Financial Health
Revenue Growth21.40%
Profit Margin20.75%
P/E Ratio24.2
ROE12.02%
ROA5.37%
Debt/Equity1.31
P/B Ratio2.8
Op. Cash Flow₹13.8B
Free Cash Flow₹14.0B
Industry P/E29.7
Technical Analysis
TrendNeutral
RSI39.5
Support₹2,922.00
Resistance₹3,408.00
MA 20₹3,202.15
MA 50₹3,137.62
MA 200₹3,502.93
MACDBearish
VolumeIncreasing
Fear & Greed Index89.14
Valuation
Fair Value₹4,639.70
Target Price₹3,472.12
Upside/Downside15.73%
GradeUndervalued
TypeBlend
Dividend Yield1.53%
Risk Assessment
Beta0.50
Volatility36.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.